Anonymous ID: 3a263a March 23, 2022, 9:30 a.m. No.15926344   🗄️.is đź”—kun   >>6362 >>6384

https://www.kansascity.com/news/nation-world/national/article259685260.html

Her husband rocks historic socks: Fashion statement at Judge Jackson’s Senate hearing

Judge Ketanji Brown Jackson’s husband, Patrick Jackson, has been seated behind her left side throughout Senate Judiciary Committee hearings, at times smiling, wiping away tears or leaning forward toward his wife.

Between breaks, they walk together to and from a set of rooms behind a granite wall bearing a United States Senate seal, during the hours-long hearings over President Joe Biden’s pick for the Supreme Court.

Anonymous ID: 3a263a March 23, 2022, 9:50 a.m. No.15926546   🗄️.is đź”—kun   >>6573 >>6615

>>15926511

>https://en.wikipedia.org/wiki/Peter_J%C3%BCni

https://ottawa.citynews.ca/local-news/research-director-to-resign-from-ontario-covid-19-science-table-5175516

Research director to resign from Ontario COVID-19 science table

Dr. Peter Juni has accepted a position at Oxford University.

The scientific director of Ontario's expert COVID-19 advisory group is resigning.

Dr. Peter Juni has accepted a position at Oxford University and is set to assume his new role in July.

A spokeswoman says Juni hasn't set a date when he will officially step down from the Ontario COVID-19 Science Advisory Table, and the group is "looking at succession planning" for his position.

Juni is a professor of medicine and epidemiology at the University of Toronto.

He is also director of a research centre at St. Michael's Hospital in the city.

The science table has published provincial disease modelling and other research on COVID-19 throughout the pandemic.

Anonymous ID: 3a263a March 23, 2022, 9:52 a.m. No.15926573   🗄️.is đź”—kun   >>6586

>>15926546

>Dr. Peter JĂĽni

JĂĽni has published over 300 scientific papers in the fields of cardiology and epidemiology, for which he has been recognized as a Highly Cited Researcher by Thomson Reuters. He is an investigator for a study to evaluate favipiravir for potential chemoprophylaxis against COVID-19 in long-term care facilities, sponsored by Appili Therapeutics.